Skip to main content
. 2020 Nov 16;49(D1):D1083–D1093. doi: 10.1093/nar/gkaa968

Figure 2.

Figure 2.

CellMinerCDB dataset overview. (A) Summary of molecular and drug activity data for the cell line sets included in CellMinerCDB. For the molecular and drug data types, the numbers indicate the number of genes or drugs. Blue numbers indicate a change in the number of features compared to the previous release, red numbers indicate new features and gray boxes denote entries for which there are no data in CellMinerCDB. (B) Number of cell line overlaps between data sources. (C) Number of single-drug activity overlaps between data sources. Abbreviations: datasets: National Cancer Institute (NCI-60), Cancer Cell Line Encyclopedia (CCLE), Cancer Therapeutics Response Portal (CTRP), Genomics of Drug Sensitivity in Cancer (GDSC), the NCI Small Cell Lung Cancer (SCLC) and the MD Anderson Cancer Center (MDACC) Cell Line Project (CLP); other: z-scores (zs), multiplatform microarray average log2 intensities (log2) and liquid chromatography–mass spectrometry (LC–MS).